Page 3 - Conserved Terminal Sequence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Conserved terminal sequence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Conserved Terminal Sequence Today - Breaking & Trending Today

Enzolytics, Inc.: Coronavirus Targeted Epitopes Claimed in Enzolytics' Pending Patent Applications are Verified as Fully Conserved in the UK, Brazil and South African Variants of the Coronavirus (SARS-COV-2)


(0)
COLLEGE STATION, TX / ACCESSWIRE / April 5, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) (or the Company ).
In a significant development, recent findings have revealed that the monoclonal antibodies being produced by the Company against targeted sites on the Coronavirus are directed against epitopes that exist conservatively on each of the variant strains of the virus from the UK, Brazil and South African.
These findings are considered by the Company as highly significant in that the Center for Disease Control (the CDC ) recently reported these Coronavirus as variants of concern, defining them as ones for which there is evidence of an increase in transmissibility, more severe disease (meaning increased hospitalizations or deaths), a significant reduction in neutralization by antibodies generated during previous infection or vaccination, reduced effectiveness of treatments or vaccines, or diagnostic detection failures. ....

United States , United Kingdom , South Africa , South African , Paul Offit , Kostenloser Wertpapierhandel , Eli Lily , Rochelle Walensky , Charles Cotropia , Eli Lilly , While Enzolytics Inc , Texasam University , Bioclonetics Immunotherapeutics Inc , Drug Administration , Research Center , Enzolytics Inc , Vaccine Education Center At Children Hospital , Institute For Preclinical , Disease Control , Artificial Intelligence , Vaccine Education Center , Immune Therapeutic , Inactivated Pepsin Fraction , College Station , Harbor Statement , Corona Virus ,